The Department of Health distributed the second shipment of the investigational antiviral medication, remdesivir, to treat patients in the hospital with COVID-19. Today, 1,548 doses of medication were sent today to 21 hospitals, and a second shipment of 6,390 doses will be distributed to 58 hospitals on Monday.
“The department is working to give our hospitals every opportunity to treat patients with COVID-19,” Secretary of Health Dr. Rachel Levine said. “It is important to note that there is limited information on the safety and effectiveness of using remdesivir to treat people in the hospital with COVID-19. However, it was shown in a clinical trial to shorten the recovery time in some people, which is why the Food and Drug Administration (FDA) has authorized the emergency use of the medication for treatment.”
The Department of Health first distributed 1,200 doses of the medication to 51 hospitals across Pennsylvania on Tuesday, May 12. The hospitals that have received these shipments were determined based on the number of COVID-19 patients at the hospital over a recent seven-day period, and the severity of the illness of those patients based on whether they are on a ventilator. The department will continue to work with our federal partners to acquire more doses of this medication to serve more patients across Pennsylvania.
Remdesivir is given to a patient through an IV once per day for up to 10 days, depending on how critically ill the patient is. According to the FDA, remdesivir may help decrease the amount of coronavirus in your body, which may help you get better faster.
Symptoms of COVID-19 can include:
- Shortness of breath or difficulty breathing
- Repeating shaking with chills
- Muscle pain
- Sore throat
- New loss of taste or smell
Symptoms may appear in as few as two days or as long as 14 days after exposure. Reported illnesses have ranged from people with little to no symptoms to people being severely ill and dying.